Acelyrin boosts IPO size, maintains expected price range

Acelyrin plans to increase its initial public offering to 26.5 million shares of its common stock.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.